Lexaria Bioscience Corp (LEXX)
2.98
-0.51
(-14.61%)
USD |
NASDAQ |
May 02, 16:00
3.02
+0.04
(+1.34%)
After-Hours: 20:00
Lexaria Bioscience Max Drawdown (5Y): 98.90% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 98.90% |
| March 31, 2024 | 98.90% |
| February 29, 2024 | 98.90% |
| January 31, 2024 | 98.90% |
| December 31, 2023 | 98.90% |
| November 30, 2023 | 98.90% |
| October 31, 2023 | 98.90% |
| September 30, 2023 | 98.90% |
| August 31, 2023 | 98.90% |
| July 31, 2023 | 98.90% |
| June 30, 2023 | 98.90% |
| May 31, 2023 | 98.90% |
| April 30, 2023 | 97.33% |
| March 31, 2023 | 97.33% |
| February 28, 2023 | 97.33% |
| January 31, 2023 | 97.33% |
| December 31, 2022 | 97.33% |
| November 30, 2022 | 97.33% |
| October 31, 2022 | 97.33% |
| September 30, 2022 | 97.33% |
| August 31, 2022 | 97.33% |
| July 31, 2022 | 97.33% |
| June 30, 2022 | 97.33% |
| May 31, 2022 | 97.33% |
| April 30, 2022 | 96.10% |
| Date | Value |
|---|---|
| March 31, 2022 | 96.06% |
| February 28, 2022 | 95.18% |
| January 31, 2022 | 94.51% |
| December 31, 2021 | 94.51% |
| November 30, 2021 | 93.96% |
| October 31, 2021 | 93.96% |
| September 30, 2021 | 93.96% |
| August 31, 2021 | 93.96% |
| July 31, 2021 | 93.96% |
| June 30, 2021 | 93.96% |
| May 31, 2021 | 93.96% |
| April 30, 2021 | 93.96% |
| March 31, 2021 | 93.96% |
| February 28, 2021 | 93.96% |
| January 31, 2021 | 93.96% |
| December 31, 2020 | 92.55% |
| November 30, 2020 | 92.55% |
| October 31, 2020 | 92.55% |
| September 30, 2020 | 89.79% |
| August 31, 2020 | 89.79% |
| July 31, 2020 | 89.79% |
| June 30, 2020 | 89.79% |
| May 31, 2020 | 89.79% |
| April 30, 2020 | 89.79% |
| March 31, 2020 | 89.79% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
85.96%
Minimum
Feb 2020
98.90%
Maximum
May 2023
94.53%
Average
93.96%
Median
Jan 2021
Max Drawdown (5Y) Benchmarks
| Aurinia Pharmaceuticals Inc | 87.58% |
| Sunshine Biopharma Inc | 100.00% |
| Acasti Pharma Inc | 98.73% |
| Edesa Biotech Inc | 99.58% |
| Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -49.76 |
| Beta (5Y) | 0.9813 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 92.07% |
| Historical Sharpe Ratio (5Y) | -0.4217 |
| Historical Sortino (5Y) | -0.7904 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.49% |